Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cimadamore A"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 43
Tytuł:
Vascular Enlargement as a Predictor of Nodal Involvement in Bladder Cancer.
Autorzy:
Borgheresi A; Department of Clinical, Special and Dental Sciences, University Politecnica delle Marche, Via Tronto 10, 60126 Ancona, Italy.; Department of Radiological Sciences, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy.
Agostini A; Department of Clinical, Special and Dental Sciences, University Politecnica delle Marche, Via Tronto 10, 60126 Ancona, Italy.; Department of Radiological Sciences, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy.
Sternardi F; Department of Radiological Sciences, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy.
Cesari E; Department of Clinical, Special and Dental Sciences, University Politecnica delle Marche, Via Tronto 10, 60126 Ancona, Italy.
Ventura F; Department of Clinical, Special and Dental Sciences, University Politecnica delle Marche, Via Tronto 10, 60126 Ancona, Italy.
Ottaviani L; Department of Radiological Sciences, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy.
Delle Fave RF; Division of Urology, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy.
Pretore E; Division of Urology, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy.
Cimadamore A; Division of Pathology, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy.; Department of Biomedical Sciences and Public Healthcare, University Politecnica delle Marche, Via Tronto 10, 60126 Ancona, Italy.
Filosa A; Division of Pathology, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy.; Department of Biomedical Sciences and Public Healthcare, University Politecnica delle Marche, Via Tronto 10, 60126 Ancona, Italy.
Galosi AB; Department of Clinical, Special and Dental Sciences, University Politecnica delle Marche, Via Tronto 10, 60126 Ancona, Italy.; Division of Urology, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy.
Giovagnoni A; Department of Clinical, Special and Dental Sciences, University Politecnica delle Marche, Via Tronto 10, 60126 Ancona, Italy.; Department of Radiological Sciences, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Jun 30; Vol. 13 (13). Date of Electronic Publication: 2023 Jun 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype.
Autorzy:
Blanca A; Department of Urology, Maimonides Biomedical Research Institute of Cordoba, University Hospital of Reina Sofia, UCO, 14004 Cordoba, Spain.
Lopez-Beltran A; Department of Morphological Sciences, University of Cordoba Medical School, 14004 Cordoba, Spain.
Lopez-Porcheron K; Department of Morphological Sciences, University of Cordoba Medical School, 14004 Cordoba, Spain.
Gomez-Gomez E; Department of Urology, Maimonides Biomedical Research Institute of Cordoba, University Hospital of Reina Sofia, UCO, 14004 Cordoba, Spain.
Cimadamore A; Department of Medical Area (DAME), Institute of Pathological Anatomy, University of Udine, 33100 Udine, Italy.
Bilé-Silva A; Urology Department, Egas Moniz Hospital, Centro Hospitalar de Lisboa Occidental, 1349-019 Lisbon, Portugal.
Gogna R; Department of Human & Molecular Genetics, VCU Institute of Molecular Medicine (VIMM), VCU Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.; BRIC-Biotech Research & Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, 1165 Copenhagen, Denmark.; Champalimaud Centre for the Unknown, 1400-038 Lisbon, Portugal.
Montironi R; Molecular Medicine and Cell Therapy Foundation, Polytechnic University of Marche, 60121 Ancona, Italy.
Cheng L; Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Lifespan Academic Medical Center, and the Legorreta Cancer Center at Brown University, Providence, RI 02903, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Apr 04; Vol. 15 (7). Date of Electronic Publication: 2023 Apr 04.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis.
Autorzy:
Del Giudice F; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, 00185 Rome, Italy.; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305-5101, USA.
Asero V; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, 00185 Rome, Italy.
Bologna E; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, 00185 Rome, Italy.
Scornajenghi CM; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, 00185 Rome, Italy.
Carino D; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, 00185 Rome, Italy.
Dolci V; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, 00185 Rome, Italy.
Viscuso P; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, 00185 Rome, Italy.
Salciccia S; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, 00185 Rome, Italy.
Sciarra A; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, 00185 Rome, Italy.
D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1030 Vienna, Austria.
Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1030 Vienna, Austria.; Department of Urology, La Croix du Sud Hospital, 31130 Quint-Fonsegrives, France.
Moschini M; Department of Urology and Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele, 20132 Milan, Italy.
Mari A; Department of Experimental and Clinical Medicine, University of Florence-Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, 50134 Florence, Italy.
Albisinni S; Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, 00133 Rome, Italy.
Krajewski W; Department of Minimally Invasive and Robotic Urology, Wrocław Medical University, 50-367 Wrocław, Poland.
Szydełko T; Department of Minimally Invasive and Robotic Urology, Wrocław Medical University, 50-367 Wrocław, Poland.
Małkiewicz B; Department of Minimally Invasive and Robotic Urology, Wrocław Medical University, 50-367 Wrocław, Poland.
Nowak Ł; Department of Minimally Invasive and Robotic Urology, Wrocław Medical University, 50-367 Wrocław, Poland.
Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1030 Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, 119435 Moscow, Russia.
Gallioli A; Department of Urology, Fundacio Puigvert, 16444 Barcelona, Spain.
Mertens LS; Department of Urology, The Netherlands Cancer Institute, 1066 Amsterdam, The Netherlands.
Marcq G; Urology Department, Claude Huriez Hospital, CHU Lille, 59000 Lille, France.; Cancer Heterogeneity Plasticity and Resistance to Therapies, UMR9020-U1277-CANTHER, Institut Pasteur de LilleCHU Lille, Inserm, CNRS University of Lille, 59000 Lille, France.
Cimadamore A; Department of Medical Area (DAME), Institute of Pathological Anatomy, University of Udine, 33100 Udine, Italy.
Afferi L; Department of Urology, Luzerner Kantonsspital, 6004 Luzern, Switzerland.
Soria F; Urology Division, Department of Surgical Sciences, University of Studies of Torino, 10124 Turin, Italy.
Mori K; Department of Urology, The Jikei University School of Medicine, Nishi-Shimbashi, Minato-ku, Tokyo 105-8461, Japan.
Tully KH; Department of Urology and Neurourology, Marien Hospital Herne, Ruhr-University Bochum, 44780 Herne, Germany.
Pichler R; Department of Urology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Ferro M; Division of Urology, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Tataru OS; Department of Simulation Applied in Medicine, The Institution Organizing University Doctoral Studies (I.O.S.U.D.), George Emil Palade University of Medicine, Pharmacy, Sciences, and Technology, 540142 Târgu Mureș, Romania.
Autorino R; Department of Urology, Rush University Medical Center, Chicago, IL 60612, USA.
Crivellaro S; Health Sciences System, Department of Urology, University of Illinois Hospital e Camp, Chicago, IL 60612, USA.
Crocetto F; Reproductive Sciences and Odontostomatology, Urology Unit, Department of Neurosciences, University of Naples 'Federico II', 80138 Naples, Italy.
Busetto GM; Department of Urology and Organ Transplantation, University of Foggia, 71122 Foggia, Italy.
Basran S; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305-5101, USA.
Eisenberg ML; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305-5101, USA.
Chung BI; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305-5101, USA.
De Berardinis E; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, 00185 Rome, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Mar 23; Vol. 15 (7). Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional series.
Autorzy:
Collins K; Departments of Pathology of Indiana University School of Medicine, Indianapolis, IN, USA.
Sholl LM; Departments of Pathology of Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Siegmund S; Departments of Pathology of Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Dickson BC; Departments of Pathology of Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Colecchia M; Departments of Pathology of Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Michalová K; Departments of Pathology of Univerzita Karlova, Plzen, Czech Republic.
Hwang M; Departments of Pathology of Indiana University School of Medicine, Indianapolis, IN, USA.
Ulbright TM; Departments of Pathology of Indiana University School of Medicine, Indianapolis, IN, USA.
Kao CS; Departments of Pathology of Stanford University, Stanford, CA, USA.
van Leenders GJLH; Departments of Pathology of Erasmus University Medical Center, Rotterdam, The Netherlands.
Mehta V; Departments of Pathology of University of Illinois at Chicago, Chicago, IL, USA.
Trpkov K; Departments of Pathology of Alberta Precision Laboratories and University of Calgary, Calgary, Alberta, Canada.
Yilmaz A; Departments of Pathology of Alberta Precision Laboratories and University of Calgary, Calgary, Alberta, Canada.
Cimadamore A; Departments of Pathology of Polytechnic University of The Marche Region, Ancona, Italy.
Matoso A; Departments of Pathology of The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Epstein JI; Departments of Pathology of The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Maclean F; Departments of Pathology of Douglass Hanly Moir Pathology and Macquarie University, Sydney, Australia.
Comperat E; Departments of Pathology of Tenon Hospital and Sorbonne University, Paris, France.
Anderson WJ; Departments of Pathology of Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Fletcher CDM; Departments of Pathology of Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Acosta AM; Departments of Pathology of Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2023 Feb; Vol. 82 (3), pp. 431-438. Date of Electronic Publication: 2022 Oct 27.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Sex Cord-Gonadal Stromal Tumors*/genetics
Sex Cord-Gonadal Stromal Tumors*/pathology
Testicular Neoplasms*/pathology
Adult ; Humans ; Male ; Chromosomes/metabolism ; DNA Copy Number Variations ; S100 Proteins ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?
Autorzy:
Marchetti A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Rosellini M; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Nuvola G; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Tassinari E; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Rizzo A; Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello', IRCCS Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124 Bari, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Cimadamore A; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Farolfi A; Nuclear Medicine Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, 40138 Bologna, Italy.
Montironi R; Molecular Medicine and Cell Therapy Foundation, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Fanti S; Nuclear Medicine Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, 40138 Bologna, Italy.
Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Feb 11; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 11.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT.
Autorzy:
Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Marchetti A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Rosellini M; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Nuvola G; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Rizzo A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Cimadamore A; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Montironi R; Molecular Medicine and Cell Therapy Foundation, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, 60100 Ancona, Italy.
Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Dec 16; Vol. 22 (24). Date of Electronic Publication: 2021 Dec 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
DNA Damage/*genetics
DNA Repair/*genetics
Prostatic Neoplasms, Castration-Resistant/*genetics
Proto-Oncogene Proteins c-akt/*genetics
Animals ; Humans ; Male ; Microsatellite Instability
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correlation between High PD-L1 and EMT/Invasive Genes Expression and Reduced Recurrence-Free Survival in Blood-Circulating Tumor Cells from Patients with Non-Muscle-Invasive Bladder Cancer.
Autorzy:
Morelli MB; School of Pharmacy, Section of Experimental Medicine, University of Camerino, 62032 Camerino, Italy.
Amantini C; School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy.
Rossi de Vermandois JA; Urologic and Andrologic Clinics, University of Perugia, 05100 Perugia, Italy.
Gubbiotti M; Department of Urology, San Donato Hospital, 52100 Arezzo, Italy.
Giannantoni A; Department of Medical and Surgical Sciences, University of Siena, 53100 Siena, Italy.; Neurosciences, Functional and Surgical Urology Unit, Santa Maria alle Scotte Hospital, 53100 Siena, Italy.
Mearini E; Urologic and Andrologic Clinics, University of Perugia, 05100 Perugia, Italy.
Maggi F; School of Pharmacy, Section of Experimental Medicine, University of Camerino, 62032 Camerino, Italy.; Department of Molecular Medicine, University Sapienza, 00185 Rome, Italy.
Nabissi M; School of Pharmacy, Section of Experimental Medicine, University of Camerino, 62032 Camerino, Italy.
Marinelli O; School of Pharmacy, Section of Experimental Medicine, University of Camerino, 62032 Camerino, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Cimadamore A; Section of Pathological Anatomy, Department of Biomedical Sciences and Public Health School of Medicine, Polytechnic University of Marche Region, Umberto I Hospitals, 60121 Ancona, Italy.
Montironi R; Molecular Medicine and Cell Therapy Foundation, Department of Clinical and Molecular Sciences, Polytechnic University of Marche Region, 60126 Ancona, Italy.
Santoni G; School of Pharmacy, Section of Experimental Medicine, University of Camerino, 62032 Camerino, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Nov 28; Vol. 13 (23). Date of Electronic Publication: 2021 Nov 28.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis.
Autorzy:
Lopez-Beltran A; Department of Morphological Sciences, University of Cordoba Medical School, E-14004 Cordoba, Spain.
Blanca A; Maimonides Biomedical Research Institute of Cordoba, Department of Urology, University Hospital of Reina Sofia, E-14004 Cordoba, Spain.
Cimadamore A; Institute of Pathological Anatomy and Histopathology, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Gogna R; Faculty of Health and Medical Sciences, BRIC-Biotech Research & Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark.; Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, University of Copenhagen, Copenhagen N, Denmark, 2200 Copenhagen, Denmark.
Montironi R; Institute of Pathological Anatomy and Histopathology, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Cheng L; Departments of Pathology and Urology, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Nov 01; Vol. 13 (21). Date of Electronic Publication: 2021 Nov 01.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views.
Autorzy:
Aurilio G; Medical Oncology Division of Urogenital and Head & Neck Cancer, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Cimadamore A; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Rizzo A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Verri E; Medical Oncology Division of Urogenital and Head & Neck Cancer, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Battelli N; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Montironi R; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Oct 18; Vol. 13 (20). Date of Electronic Publication: 2021 Oct 18.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Coronavirus Disease 2019 (COVID-19) Pandemic's Impact on Social Interaction in Pathology.
Autorzy:
Montironi R; Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
Cimadamore A; Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
Cheng L; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis.
Lopez-Beltran A; Department of Morphological Sciences, Cordoba University Medical School, Cordoba, Spain.
Scarpelli M; Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 Sep 01; Vol. 145 (9), pp. 1049-1050.
Typ publikacji:
Letter; Comment
MeSH Terms:
COVID-19*
Pandemics*
Humans ; SARS-CoV-2 ; Social Interaction
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation.
Autorzy:
Cimadamore A; Section of Pathological Anatomy, United Hospitals, School of Medicine, Polytechnic University of the Marche Region, Via Conca 71, 60126 Ancona, Italy.
Mazzucchelli R; Section of Pathological Anatomy, United Hospitals, School of Medicine, Polytechnic University of the Marche Region, Via Conca 71, 60126 Ancona, Italy.
Lopez-Beltran A; Department of Morphological Sciences, Cordoba University Medical School, 14071 Cordoba, Spain.
Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna; Via Albertoni n. 15, 40138 Bologna, Italy.
Santoni M; Oncology Unit, Macerata Hospital, Via Santa Lucia 2, 62100 Macerata, Italy.
Scarpelli M; Section of Pathological Anatomy, United Hospitals, School of Medicine, Polytechnic University of the Marche Region, Via Conca 71, 60126 Ancona, Italy.
Cheng L; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Montironi R; Section of Pathological Anatomy, United Hospitals, School of Medicine, Polytechnic University of the Marche Region, Via Conca 71, 60126 Ancona, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Jul 11; Vol. 13 (14). Date of Electronic Publication: 2021 Jul 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory?
Autorzy:
Marchetti A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Rosellini M; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Rizzo A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Tassinari E; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Nuvola G; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Cimadamore A; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Fiorentino M; Department of Specialistic Diagnostic and Experimental Medicine, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Montironi R; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni-15, 40138 Bologna, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Jun 09; Vol. 22 (12). Date of Electronic Publication: 2021 Jun 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Biomarkers, Tumor*/antagonists & inhibitors
Biomarkers, Tumor*/metabolism
Carcinoma, Renal Cell*/drug therapy
Carcinoma, Renal Cell*/metabolism
Carcinoma, Renal Cell*/pathology
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/metabolism
Kidney Neoplasms*/pathology
Proto-Oncogene Proteins c-met*/antagonists & inhibitors
Proto-Oncogene Proteins c-met*/metabolism
TOR Serine-Threonine Kinases*/antagonists & inhibitors
TOR Serine-Threonine Kinases*/metabolism
Protein Kinase Inhibitors/*therapeutic use
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic.
Autorzy:
Cimadamore A; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Cheng L; Department of Pathology and Laboratory Medicine, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Pepi L; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Franzese C; Department of Specialist Clinical Science and Odontostomatology, Urology Division, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Scarpelli M; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Lopez-Beltran A; Department of Morphological Sciences, Cordoba University Medical School, 14071 Cordoba, Spain.
Galosi AB; Department of Specialist Clinical Science and Odontostomatology, Urology Division, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Montironi R; Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, 60126 Ancona, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 May 24; Vol. 22 (11). Date of Electronic Publication: 2021 May 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Mutation*
Recombinational DNA Repair*
Circulating Tumor DNA/*blood
Neoplasm Proteins/*genetics
Prostatic Neoplasms, Castration-Resistant/*diagnosis
Ataxia Telangiectasia Mutated Proteins/genetics ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Humans ; Liquid Biopsy ; Male ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/genetics ; Sequence Analysis, DNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection limits of significant prostate cancer using multiparametric MR and digital rectal examination in men with low serum PSA: Up-date of the Italian Society of Integrated Diagnostic in Urology.
Autorzy:
Galosi AB; Division of Urology, School of Medicine, Università Politecnica delle Marche, Ancona. a..
Palagonia E; Division of Urology, School of Medicine, Università Politecnica delle Marche, Ancona. .
Scarcella S; Division of Urology, School of Medicine, Università Politecnica delle Marche, Ancona. .
Cimadamore A; Division of Pathology, School of Medicine, Università Politecnica delle Marche, Ancona. a.cimadamore@staff.univpm.it.
Lacetera V; Division of Urology, Azienda Ospedaliera Marche Nord, Pesaro. .
Delle Fave RF; Division of Urology, School of Medicine, Università Politecnica delle Marche, Ancona. .
Antezza A; Division of Urology, School of Medicine, Università Politecnica delle Marche, Ancona. .
Dell'Atti L; Division of Urology, School of Medicine, Università Politecnica delle Marche, Ancona. .
Pokaż więcej
Źródło:
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2021 Mar 22; Vol. 93 (1), pp. 92-100. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Digital Rectal Examination*
Multiparametric Magnetic Resonance Imaging*
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*blood
Prostatic Neoplasms/*diagnosis
Humans ; Italy ; Male ; Practice Guidelines as Topic ; Prostatic Neoplasms/diagnostic imaging ; Societies, Medical ; Urology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Treating Prostate Cancer by Antibody-Drug Conjugates.
Autorzy:
Rosellini M; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Mollica V; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Rizzo A; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Cimadamore A; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Scarpelli M; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Storti N; Direzione Sanitaria Azienda Sanitaria Unica Regionale, 60122 Ancona, Italy.
Battelli N; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Montironi R; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Massari F; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Feb 04; Vol. 22 (4). Date of Electronic Publication: 2021 Feb 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antineoplastic Agents, Immunological/*therapeutic use
Immunoconjugates/*therapeutic use
Prostatic Neoplasms/*drug therapy
Animals ; Antineoplastic Agents, Immunological/pharmacology ; Biomarkers, Tumor ; Clinical Trials as Topic ; Disease Management ; Disease Susceptibility ; Humans ; Immunoconjugates/pharmacology ; Male ; Molecular Targeted Therapy ; Prognosis ; Prostatic Neoplasms/etiology ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/etiology ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology ; Standard of Care ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art.
Autorzy:
Mollica V; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Rizzo A; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Rosellini M; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Marchetti A; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Ricci AD; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Cimadamore A; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60121 Ancona, Italy.
Scarpelli M; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60121 Ancona, Italy.
Bonucci C; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Andrini E; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Errani C; Department of Musculo-Skeletal Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Montironi R; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60121 Ancona, Italy.
Massari F; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Feb 01; Vol. 13 (3). Date of Electronic Publication: 2021 Feb 01.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors.
Autorzy:
Giulietti M; Department of Specialistic Clinical & Odontostomatological Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.
Cecati M; Department of Specialistic Clinical & Odontostomatological Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.
Sabanovic B; Department of Specialistic Clinical & Odontostomatological Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.
Scirè A; Department of Life and Environmental Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.
Cimadamore A; Section of Pathological Anatomy, Polytechnic University of Marche, United Hospitals, 60126 Ancona, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62012 Macerata, Italy.
Montironi R; Section of Pathological Anatomy, Polytechnic University of Marche, United Hospitals, 60126 Ancona, Italy.
Piva F; Department of Specialistic Clinical & Odontostomatological Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2021 Jan 30; Vol. 11 (2). Date of Electronic Publication: 2021 Jan 30.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?
Autorzy:
Santoni M; Oncology Unit, Macerata Hospital, Via Santa Lucia 2, 62100 Macerata, Italy.
Massari F; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.
Bracarda S; Medical and Translational Oncology Unit, Department of Oncology, AziendaOspedaliera Santa Maria, 05100 Terni, Italy.
Procopio G; Department of Medical Oncology, Istituto Nazionale dei Tumori IRCCS, 20133 Milan, Italy.
Milella M; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust (AOUI Verona), P.le L.A. Scuro 10, 37134 Verona, Italy.
De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.
Basso U; Department of Medical Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128 Padova, Italy.
Aurilio G; Medical Oncology Division of Urogenital and Head and Neck Tumours, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Incorvaia L; Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), Section of Medical Oncology, University of Palermo, 90127 Palermo, Italy.
Martignetti A; Dipartimento Oncologico USL Sud-Est Toscana-Area Senese, Località Campostaggia s.n.c., 53036 Poggibonsi, Italy.
Rizzo M; Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, 27100 Pavia, Italy.
Cartenì G; Department of Medical Oncology, AO 'A. Cardarelli', 80131 Naples, Italy.
Grande E; Department of Medical Oncology, MD Anderson Cancer Center, 28033 Madrid, Spain.
Matrana MR; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA 70121, USA.
Crabb SJ; Southampton Clinical Trials Unit, University of Southampton, Southampton SO16 5AF, UK.
Vau N; Urologic Oncology, Champalimaud Clinical Center, 1400-038 Lisbon, Portugal.
Sorgentoni G; Oncology Unit, Macerata Hospital, Via Santa Lucia 2, 62100 Macerata, Italy.
Cimadamore A; Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, 60126 Ancona, Italy.
Montironi R; Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, 60126 Ancona, Italy.
Battelli N; Oncology Unit, Macerata Hospital, Via Santa Lucia 2, 62100 Macerata, Italy.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2021 Jan 18; Vol. 11 (1). Date of Electronic Publication: 2021 Jan 18.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer.
Autorzy:
Lopez-Beltran A; Unit of Anatomic Pathology, Department of Morphological Sciences, Cordoba University Medical School, 14004 Cordoba, Spain.
Cimadamore A; Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Blanca A; Maimonides Biomedical Research Institute of Cordoba, Department of Urology, University Hospital of Reina Sofia, 14004 Cordoba, Spain.
Massari F; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Vau N; Medical Oncology, Champalimaud Clinical Center, 1400-038 Lisbon, Portugal.
Scarpelli M; Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Cheng L; Department of Pathology and Laboratory Medicine, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
Montironi R; Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Jan 03; Vol. 13 (1). Date of Electronic Publication: 2021 Jan 03.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Wide Spectrum of Oncocytic Changes and Tumors in the Kidney: Splitting and Lumping.
Autorzy:
Cimadamore A; Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
Lopez-Beltran A; Department of Pathology and Surgery, Faculty of Medicine, Córdoba, Spain.
Scarpelli M; Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
Cheng L; Department of Pathology and Laboratory Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Montironi R; Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.
Pokaż więcej
Źródło:
Pathobiology : journal of immunopathology, molecular and cellular biology [Pathobiology] 2021; Vol. 88 (5), pp. 323-326. Date of Electronic Publication: 2021 May 11.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Adenoma, Oxyphilic*/diagnosis
Kidney Neoplasms*/diagnosis
Humans ; Kidney
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 43

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies